Study Shows How Stress And Heart Problems May Be Linked
Kate Kelland reporting for Reuters stated that research published in The Lancet suggests individuals “with heightened activity in the amygdala, an area of the brain linked to stress, may be at greater risk of heart disease and stroke.”
Jacqueline Howard writing for CNN reported that the study included nearly 300 “adults who underwent PET and CT scans…between 2005 and 2008.” These “scans recorded brain activity, bone marrow activity, spleen activity and inflammation in the heart arteries.” The investigators then “tracked the health of each patient for two to five years, during which 22 of the patients had a cardiovascular disease event.”
Comment: Stress reduction is essential to preventing cardiac events.
As if patients with ankylosing spondylitis didn’t have enough to worry about…
Patients with Ankylosing spondylitis have increased risk of heart attack and stroke.
Haroon and colleagues from the University of Toronto compared the relative risk of heart attack and stroke between 21,473 patients with ankylosing spondylitis and 86,606 age and gender matched control patients. They found that the incidence of both disorders was increased in patients with ankylosing spondylitis. Risk factors included male gender, age, lower income, dementia, chronic kidney disease, and peripheral vascular disease. The study was published in the Annals of Internal Medicine.
Stem cells effective in healing damage from heart attacks.
Krystal Phend reported in Medpage Today that a recent study published in Circulation Research showed autologous stem cell injections long after a heart attack can help enlarged hearts recover in size and function. Researchers reported that the “treatment showed improvements in cardiac chamber dimensions and contractility through the end of one year of follow-up. What’s this have to do with arthritis? Well… obviously, another study showing that autologous stem cells may work in a number of different medical conditions.
Eswar Krishnan and Jeremy Sokolove in the journal Current Opinion in Rheumatol reviewed the recently published data on elevated blood uric acid levels and cardiovascular disease. Evidence has accumulated in prospective observational studies that link hyperuricemia with the risk of hypertension. Newer data confirmed the link between hyperuricemia and cardiovascular mortality. The use of allopurinol has been shown to be associated with reduced mortality risk and with reduced blood pressure in short-term randomized controlled trials. The available evidence has established a link between hyperuricemia and cardiovascular disease and this may be causal. One can start using serum uric acid concentration as an inexpensive cardiovascular risk marker.